Journal article · 2022 · Open access

Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey

Nadia Azmi Nabulsi, Khatija W. Naing, Huiwen Deng, Jenilee Cueto, Alemseged Ayele Asfaw, Colin C. Hubbard, Jifang Zhou, In-Young Lee, Debanjali Mitra, Gregory Sampang Calip, Ernest H. Law

Journal of Patient Experience, 9, 23743735221113058 · Published 1 January 2022 · DOI 10.1177/23743735221113058

Open PDFView at the publisherCite this paper

In brief

“Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey” is a 2022 journal article by Nadia Azmi Nabulsi and 10 co-authors, published in Journal of Patient Experience. OpenAlex counts 0 citations as of 22 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Journal of Patient Experience.

Citations
0
References
29
Authors
11

Abstract

This study describes health-related quality of life (HRQoL) among older Medicare beneficiaries with hormone receptor-positive (HR+) early breast cancer (eBC). Women aged ≥65 years diagnosed with stage I-III HR+ eBC between 1997 and 2014 using the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey Data Resource were included. HRQoL was measured using the Short Form Health Survey including physical/mental component summary (PCS/MCS) scores and subscales. Patient surveys ≤ 24 months post-diagnosis were matched to non-cancer controls. Mean differences in HRQoL were compared using analysis of covariance. Among 1880 HR+ eBC patients versus 5640 matched non-cancer controls, eBC patients surveyed ≤ 6 months post-diagnosis (n = 530) scored lower on component scores (PCS mean difference = 1.6 [95%CI: 0.6-2.6]; MCS mean difference = 2.0 [95%CI: 1.0-3.0]) and multiple subscales. Among women surveyed 19 to 24 months post-diagnosis (n = 402), mean differences in HRQoL were modest (PCS: 1.2 [95%CI: 0.1-2.4]; MCS: -1.5 [95%CI: -2.7 to -0.3]). Most differences in HRQoL following diagnosis of eBC did not indicate statistical significance or minimally important difference, emphasizing that preservation of HRQoL is an important and realistic goal among patients with eBC.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Nabulsi, N. A., Naing, K. W., Deng, H., Cueto, J., Asfaw, A. A., Hubbard, C. C., Zhou, J., Lee, I.-Y., Mitra, D., Calip, G. S., & Law, E. H. (2022). Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey. Journal of Patient Experience, 9, 23743735221113058. https://doi.org/10.1177/23743735221113058

MLA 9

Nabulsi, Nadia Azmi, et al. “Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey.” Journal of Patient Experience, vol. 9, 2022, p. 23743735221113058. https://doi.org/10.1177/23743735221113058.

Chicago

Nabulsi, Nadia Azmi, Khatija W. Naing, Huiwen Deng, Jenilee Cueto, Alemseged Ayele Asfaw, Colin C. Hubbard, Jifang Zhou, et al. 2022. “Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey.” Journal of Patient Experience 9: 23743735221113058. https://doi.org/10.1177/23743735221113058.

Harvard

Nabulsi, N. A. et al. (2022) ‘Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey’, Journal of Patient Experience, 9, p. 23743735221113058. doi:10.1177/23743735221113058.

IEEE

N. A. Nabulsi et al., “Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey,” Journal of Patient Experience, vol. 9, p. 23743735221113058, 2022, doi: 10.1177/23743735221113058.

BibTeX

@article{nabulsi2022health,
  title     = {{Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey}},
  author    = {Nabulsi, Nadia Azmi and Naing, Khatija W. and Deng, Huiwen and Cueto, Jenilee and Asfaw, Alemseged Ayele and Hubbard, Colin C. and Zhou, Jifang and Lee, In-Young and Mitra, Debanjali and Calip, Gregory Sampang and Law, Ernest H.},
  journal   = {Journal of Patient Experience},
  year      = {2022},
  volume    = {9},
  pages     = {23743735221113058},
  doi       = {10.1177/23743735221113058},
  url       = {https://doi.org/10.1177/23743735221113058}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • health-related quality of life
  • hormone receptor-positive breast cancer
  • early breast cancer
  • older women
  • Medicare beneficiaries
  • physical component summary
  • mental component summary
  • Short Form Health Survey

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Nabulsi, N. A., Naing, K. W., Deng, H., Cueto, J., Asfaw, A. A., Hubbard, C. C., Zhou, J., Lee, I.-Y., Mitra, D., Calip, G. S., & Law, E. H. (2022). Health-related Quality of Life in Hormone Receptor-Positive Early Breast Cancer: Analyses From the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey. Journal of Patient Experience, 9, 23743735221113058. https://doi.org/10.1177/23743735221113058

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Patient Experience: sign in and open the PDF from this page.

Who wrote this paper?

Nadia Azmi Nabulsi, Khatija W. Naing, Huiwen Deng, Jenilee Cueto, Alemseged Ayele Asfaw, Colin C. Hubbard, Jifang Zhou, In-Young Lee, Debanjali Mitra, Gregory Sampang Calip, Ernest H. Law.

What is the DOI of this paper?

10.1177/23743735221113058, permanently at https://doi.org/10.1177/23743735221113058. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.